150 related articles for article (PubMed ID: 35402271)
1. Sex, Gender and Age Differences in Treatment Allocation and Survival of Patients With Metastatic Pancreatic Cancer: A Nationwide Study.
Pijnappel EN; Schuurman M; Wagner AD; de Vos-Geelen J; van der Geest LGM; de Groot JB; Koerkamp BG; de Hingh IHJT; Homs MYV; Creemers GJ; Cirkel GA; van Santvoort HC; Busch OR; Besselink MG; van Eijck CHJ; Wilmink JW; van Laarhoven HWM
Front Oncol; 2022; 12():839779. PubMed ID: 35402271
[TBL] [Abstract][Full Text] [Related]
2. Gender differences in tumor characteristics, treatment allocation and survival in stage I-III pancreatic cancer: a nationwide study.
Gehrels AM; Wagner AD; Besselink MG; Verhoeven RHA; van Eijck CHJ; van Laarhoven HWM; Wilmink JW; van der Geest LG;
Eur J Cancer; 2024 May; 206():114117. PubMed ID: 38781719
[TBL] [Abstract][Full Text] [Related]
3. Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: A Population-Based Study.
Dijksterhuis WPM; Kalff MC; Wagner AD; Verhoeven RHA; Lemmens VEPP; van Oijen MGH; Gisbertz SS; van Berge Henegouwen MI; van Laarhoven HWM
J Natl Cancer Inst; 2021 Nov; 113(11):1551-1560. PubMed ID: 33837791
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence study.
Dijksterhuis WPM; Verhoeven RHA; Slingerland M; Haj Mohammad N; de Vos-Geelen J; Beerepoot LV; van Voorthuizen T; Creemers GJ; van Oijen MGH; van Laarhoven HWM
Int J Cancer; 2020 Apr; 146(7):1889-1901. PubMed ID: 31340065
[TBL] [Abstract][Full Text] [Related]
5. Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands.
Haj Mohammad N; Bernards N; Besselink MG; Busch OR; Wilmink JW; Creemers GJ; De Hingh IH; Lemmens VE; van Laarhoven HW
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1353-60. PubMed ID: 26995276
[TBL] [Abstract][Full Text] [Related]
6. Nationwide trends in chemotherapy use and survival of elderly patients with metastatic pancreatic cancer.
van der Geest LGM; Haj Mohammad N; Besselink MGH; Lemmens VEPP; Portielje JEA; van Laarhoven HWM; Wilmink JHW;
Cancer Med; 2017 Dec; 6(12):2840-2849. PubMed ID: 29035014
[TBL] [Abstract][Full Text] [Related]
7. Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer.
Graus MUJE; de Hingh IHJT; Besselink MG; Bruno MJ; Wilmink JW; de Meijer VE; van Velthuysen MF; Valkenburg-van Iersel LBJ; van der Geest LGM; de Vos-Geelen J; ; ;
HPB (Oxford); 2023 Oct; 25(10):1195-1202. PubMed ID: 37236831
[TBL] [Abstract][Full Text] [Related]
8. In real life, one-quarter of patients with hormone receptor-positive metastatic breast cancer receive chemotherapy as initial palliative therapy: a study of the Southeast Netherlands Breast Cancer Consortium.
Lobbezoo DJ; van Kampen RJ; Voogd AC; Dercksen MW; van den Berkmortel F; Smilde TJ; van de Wouw AJ; Peters FP; van Riel JM; Peters NA; de Boer M; Peer PG; Tjan-Heijnen VC
Ann Oncol; 2016 Feb; 27(2):256-62. PubMed ID: 26578730
[TBL] [Abstract][Full Text] [Related]
9. Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: A population-based study.
Dijksterhuis WPM; Verhoeven RHA; Pape M; Slingerland M; Haj Mohammad N; de Vos-Geelen J; Beerepoot LV; van Voorthuizen T; Creemers GJ; Lemmens VEPP; van Oijen MGH; van Laarhoven HWM
Eur J Cancer; 2020 Nov; 139():107-118. PubMed ID: 32980749
[TBL] [Abstract][Full Text] [Related]
10. Impact of palliative therapies in metastatic esophageal cancer patients not receiving chemotherapy.
Kim S; DiPeri TP; Guan M; Placencio-Hickok VR; Kim H; Liu JY; Hendifar A; Klempner SJ; Nipp R; Gangi A; Burch M; Waters K; Cho M; Chao J; Atkins K; Kamrava M; Tuli R; Gong J
World J Gastrointest Surg; 2020 Sep; 12(9):377-389. PubMed ID: 33024512
[TBL] [Abstract][Full Text] [Related]
11. The fear of cancer recurrence and progression in patients with pancreatic cancer.
Pijnappel EN; Dijksterhuis WPM; Sprangers MAG; Augustinus S; de Vos-Geelen J; de Hingh IHJT; Molenaar IQ; Busch OR; Besselink MG; Wilmink JW; van Laarhoven HWM;
Support Care Cancer; 2022 Jun; 30(6):4879-4887. PubMed ID: 35169873
[TBL] [Abstract][Full Text] [Related]
12. Surgical resection of a primary tumor improves survival of metastatic pancreatic cancer: a population-based study.
Tao L; Yuan C; Ma Z; Jiang B; Xiu D
Cancer Manag Res; 2017; 9():471-479. PubMed ID: 29056856
[TBL] [Abstract][Full Text] [Related]
13. A population-based study in synchronous
Pape M; Vissers PAJ; Bertwistle D; McDonald L; Slingerland M; Haj Mohammad N; Beerepoot LV; Ruurda JP; Nieuwenhuijzen GAP; Jeene PM; van Laarhoven HWM; Verhoeven RHA
Ther Adv Med Oncol; 2022; 14():17588359221085557. PubMed ID: 35356260
[TBL] [Abstract][Full Text] [Related]
14. Ten weeks to live: a population-based study on treatment and survival of patients with metastatic pancreatic cancer in the south of the Netherlands.
Bernards N; Haj Mohammad N; Creemers GJ; de Hingh IH; van Laarhoven HW; Lemmens VE
Acta Oncol; 2015 Mar; 54(3):403-10. PubMed ID: 25263080
[TBL] [Abstract][Full Text] [Related]
15. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
[TBL] [Abstract][Full Text] [Related]
16. Incidence, risk factors, treatment, and survival of ovarian metastases of colorectal origin: a Dutch population-based study.
Bakkers C; van der Meer R; Roumen RM; Lurvink RJ; Lemmens VE; van Erning FN; de Hingh IH
Int J Colorectal Dis; 2020 Jun; 35(6):1035-1044. PubMed ID: 32157379
[TBL] [Abstract][Full Text] [Related]
17. Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort study.
Dijksterhuis WPM; Verhoeven RHA; Meijer SL; Slingerland M; Haj Mohammad N; de Vos-Geelen J; Beerepoot LV; van Voorthuizen T; Creemers GJ; van Oijen MGH; van Laarhoven HWM
Gastric Cancer; 2020 Jul; 23(4):579-590. PubMed ID: 31927675
[TBL] [Abstract][Full Text] [Related]
18. Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy.
Francini E; Montagnani F; Nuzzo PV; Gonzalez-Velez M; Alimohamed NS; Rosellini P; Moreno-Candilejo I; Cigliola A; Rubio-Perez J; Crivelli F; Shaw GK; Zhang L; Petrioli R; Bengala C; Francini G; Garcia-Foncillas J; Sweeney CJ; Higano CS; Bryce AH; Harshman LC; Lee-Ying R; Heng DYC
JAMA Netw Open; 2021 Jul; 4(7):e2116536. PubMed ID: 34292336
[TBL] [Abstract][Full Text] [Related]
19. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.
Domínguez-Muñoz JE; Nieto-Garcia L; López-Díaz J; Lariño-Noia J; Abdulkader I; Iglesias-Garcia J
BMC Cancer; 2018 May; 18(1):534. PubMed ID: 29728096
[TBL] [Abstract][Full Text] [Related]
20. Impact of socioeconomic status on presentation, treatment and outcomes of patients with pancreatic cancer.
Abdel-Rahman O
J Comp Eff Res; 2020 Dec; 9(17):1233-1241. PubMed ID: 33275039
[No Abstract] [Full Text] [Related]
[Next] [New Search]
